2017 ESCMID/ECMM/ERS指南:曲霉菌病的诊断和管理

2018-03-12 欧洲临床微生物与感染性疾病学会 Clin Microbiol Infect. 2018 Mar 12.

2017欧洲曲霉菌病的诊断和管理指南是由欧洲临床微生物与感染性疾病学会(ESCMID)、欧洲医学真菌学联盟(ECMM)联合欧洲呼吸学会(ERS)联合制定。指南建议内容涉及诊断程序,胸部影像学检查,支气管肺泡灌洗和活组织检查,其他位置影像学检查,显微镜下检查以及抗真菌药敏测试等。

中文标题:

2017 ESCMID/ECMM/ERS指南:曲霉菌病的诊断和管理

英文标题:

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.

发布日期:

2018-03-12

简要介绍:

2017欧洲曲霉菌病的诊断和管理指南是由欧洲临床微生物与感染性疾病学会(ESCMID)、欧洲医学真菌学联盟(ECMM)联合欧洲呼吸学会(ERS)联合制定。指南建议内容涉及诊断程序,胸部影像学检查,支气管肺泡灌洗和活组织检查,其他位置影像学检查,显微镜下检查以及抗真菌药敏测试等。

 

拓展指南:霉菌相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2017 ESCMID/ECMM/ERS指南:曲霉菌病的诊断和管理)] GetToolGuiderByIdResponse(projectId=1, id=9f88b1c0015698a0, title=2017 ESCMID/ECMM/ERS指南:曲霉菌病的诊断和管理, enTitle=Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline., guiderFrom=Clin Microbiol Infect. 2018 Mar 12., authorId=null, author=, summary=2017欧洲曲霉菌病的诊断和管理指南是由欧洲临床微生物与感染性疾病学会(ESCMID)、欧洲医学真菌学联盟(ECMM)联合欧洲呼吸学会(ERS)联合制定。指南建议内容涉及诊断程序,胸部影像学检查,支气管肺泡灌洗和活组织检查,其他位置影像学检查,显微镜下检查以及抗真菌药敏测试等。 , cover=, journalId=null, articlesId=null, associationId=166, associationName=欧洲临床微生物与感染性疾病学会, associationIntro=欧洲临床微生物与感染性疾病学会(ESCMID)成立于1983年,在德国注册。现在世界各地的正式会员有4100余人。它在微生物学和传染病学领域具有一定的影响力。, copyright=0, guiderPublishedTime=Mon Mar 12 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>2017欧洲曲霉菌病的诊断和管理指南是由欧洲临床微生物与感染性疾病学会(ESCMID)、欧洲医学真菌学联盟(ECMM)联合欧洲呼吸学会(ERS)联合制定。指南建议内容涉及诊断程序,胸部影像学检查,支气管肺泡灌洗和活组织检查,其他位置影像学检查,显微镜下检查以及抗真菌药敏测试等。 </P> <P> </P>拓展指南:<strong>与<font color=red>霉菌</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=9f4aa1c00122e695" title="2016IDSA:曲霉菌感染临床实践指南" target=_blank>2016IDSA:曲霉菌感染临床实践指南</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=3a3661c0010a2254" title="2013 ESCMID/ECMM联合临床指南:毛霉菌病的诊断和管理" target=_blank>2013 ESCMID/ECMM联合临床指南:毛霉菌病的诊断和管理</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E9%9C%89%E8%8F%8C" target=_blank>有关霉菌更多指南</a></ul>, tagList=[TagDto(tagId=70530, tagName=:), TagDto(tagId=71969, tagName=曲霉菌病)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10495, appHits=606, showAppHits=6, pcHits=6863, showPcHits=4777, likes=117, shares=27, comments=12, approvalStatus=1, publishedTime=Tue Mar 20 21:14:49 CST 2018, publishedTimeString=2018-03-12, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Mar 20 21:14:49 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 10:21:23 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017 ESCMID/ECMM/ERS指南:曲霉菌病的诊断和管理)])
2017 ESCMID/ECMM/ERS指南:曲霉菌病的诊断和管理
下载请点击:
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1052005, encodeId=ca2f1052005af, content=文章不错 受教了 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Thu Sep 16 15:33:46 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002869, encodeId=776b100286971, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c68d5557440, createdName=ms3000000638617419, createdTime=Mon Jul 26 22:47:48 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969724, encodeId=dc61969e2466, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/c2593ea8bbed438ea1f95cbdf556c768/2fc9aa157cab40fe91945be182d37ff3.jpg, createdBy=e69f5417776, createdName=ms3000001354807136, createdTime=Sun May 30 23:35:39 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969723, encodeId=4cc2969e23b2, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/c2593ea8bbed438ea1f95cbdf556c768/2fc9aa157cab40fe91945be182d37ff3.jpg, createdBy=e69f5417776, createdName=ms3000001354807136, createdTime=Sun May 30 23:35:36 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969722, encodeId=8d09969e2279, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/c2593ea8bbed438ea1f95cbdf556c768/2fc9aa157cab40fe91945be182d37ff3.jpg, createdBy=e69f5417776, createdName=ms3000001354807136, createdTime=Sun May 30 23:35:31 CST 2021, time=2021-05-30, status=1, ipAttribution=)]
    2021-09-16 H8888888

    文章不错 受教了 谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1052005, encodeId=ca2f1052005af, content=文章不错 受教了 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Thu Sep 16 15:33:46 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002869, encodeId=776b100286971, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c68d5557440, createdName=ms3000000638617419, createdTime=Mon Jul 26 22:47:48 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969724, encodeId=dc61969e2466, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/c2593ea8bbed438ea1f95cbdf556c768/2fc9aa157cab40fe91945be182d37ff3.jpg, createdBy=e69f5417776, createdName=ms3000001354807136, createdTime=Sun May 30 23:35:39 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969723, encodeId=4cc2969e23b2, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/c2593ea8bbed438ea1f95cbdf556c768/2fc9aa157cab40fe91945be182d37ff3.jpg, createdBy=e69f5417776, createdName=ms3000001354807136, createdTime=Sun May 30 23:35:36 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969722, encodeId=8d09969e2279, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/c2593ea8bbed438ea1f95cbdf556c768/2fc9aa157cab40fe91945be182d37ff3.jpg, createdBy=e69f5417776, createdName=ms3000001354807136, createdTime=Sun May 30 23:35:31 CST 2021, time=2021-05-30, status=1, ipAttribution=)]
    2021-07-26 ms3000000638617419

    谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1052005, encodeId=ca2f1052005af, content=文章不错 受教了 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Thu Sep 16 15:33:46 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002869, encodeId=776b100286971, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c68d5557440, createdName=ms3000000638617419, createdTime=Mon Jul 26 22:47:48 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969724, encodeId=dc61969e2466, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/c2593ea8bbed438ea1f95cbdf556c768/2fc9aa157cab40fe91945be182d37ff3.jpg, createdBy=e69f5417776, createdName=ms3000001354807136, createdTime=Sun May 30 23:35:39 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969723, encodeId=4cc2969e23b2, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/c2593ea8bbed438ea1f95cbdf556c768/2fc9aa157cab40fe91945be182d37ff3.jpg, createdBy=e69f5417776, createdName=ms3000001354807136, createdTime=Sun May 30 23:35:36 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969722, encodeId=8d09969e2279, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/c2593ea8bbed438ea1f95cbdf556c768/2fc9aa157cab40fe91945be182d37ff3.jpg, createdBy=e69f5417776, createdName=ms3000001354807136, createdTime=Sun May 30 23:35:31 CST 2021, time=2021-05-30, status=1, ipAttribution=)]
    2021-05-30 ms3000001354807136

    可以

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1052005, encodeId=ca2f1052005af, content=文章不错 受教了 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Thu Sep 16 15:33:46 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002869, encodeId=776b100286971, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c68d5557440, createdName=ms3000000638617419, createdTime=Mon Jul 26 22:47:48 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969724, encodeId=dc61969e2466, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/c2593ea8bbed438ea1f95cbdf556c768/2fc9aa157cab40fe91945be182d37ff3.jpg, createdBy=e69f5417776, createdName=ms3000001354807136, createdTime=Sun May 30 23:35:39 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969723, encodeId=4cc2969e23b2, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/c2593ea8bbed438ea1f95cbdf556c768/2fc9aa157cab40fe91945be182d37ff3.jpg, createdBy=e69f5417776, createdName=ms3000001354807136, createdTime=Sun May 30 23:35:36 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969722, encodeId=8d09969e2279, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/c2593ea8bbed438ea1f95cbdf556c768/2fc9aa157cab40fe91945be182d37ff3.jpg, createdBy=e69f5417776, createdName=ms3000001354807136, createdTime=Sun May 30 23:35:31 CST 2021, time=2021-05-30, status=1, ipAttribution=)]
    2021-05-30 ms3000001354807136

    可以

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1052005, encodeId=ca2f1052005af, content=文章不错 受教了 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Thu Sep 16 15:33:46 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002869, encodeId=776b100286971, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c68d5557440, createdName=ms3000000638617419, createdTime=Mon Jul 26 22:47:48 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969724, encodeId=dc61969e2466, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/c2593ea8bbed438ea1f95cbdf556c768/2fc9aa157cab40fe91945be182d37ff3.jpg, createdBy=e69f5417776, createdName=ms3000001354807136, createdTime=Sun May 30 23:35:39 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969723, encodeId=4cc2969e23b2, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/c2593ea8bbed438ea1f95cbdf556c768/2fc9aa157cab40fe91945be182d37ff3.jpg, createdBy=e69f5417776, createdName=ms3000001354807136, createdTime=Sun May 30 23:35:36 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969722, encodeId=8d09969e2279, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/c2593ea8bbed438ea1f95cbdf556c768/2fc9aa157cab40fe91945be182d37ff3.jpg, createdBy=e69f5417776, createdName=ms3000001354807136, createdTime=Sun May 30 23:35:31 CST 2021, time=2021-05-30, status=1, ipAttribution=)]
    2021-05-30 ms3000001354807136

    加油

    0